Category: Revenue Cycle Management

Key Healthcare Financial Technology Trends For 2021

Key Healthcare Financial Technology Trends For 2021

  More than 80% of survey respondents stated that they have confidence in their organization’s ability to “rapidly adjust their plans and strategies.” Healthcare finance leaders are more optimistic about the ability to adjust to a changing business environment and utilize quality data in the decision-making process, according to the 2021 Healthcare Financial Trends Survey report released […]
Learn More
CMS Accelerates Medicare Beneficiaries’ Access to Innovations

CMS Accelerates Medicare Beneficiaries’ Access to Innovations

Medicare beneficiaries now have immediate access to innovative medical technology approved by the U.S. Food and Drug Administration (FDA), rather than having to wait for it to clear additional bureaucratic hurdles before coverage is approved. The Medicare Coverage of Innovative Technology (MCIT) final rule issued this week eliminates the time and cost innovators were formerly […]
Learn More
Recovering From Covid-19_ How Practices Can Maintain the Revenue Cycle In 2021

Recovering From Covid-19: How Practices Can Maintain the Revenue Cycle In 2021

  Five tips for improving RCM in a post-pandemic world As a result of the COVID-19 pandemic, the American Hospital Association (AHA) estimates that hospitals and health systems have lost more than $202 billion from a drop in revenue, combined with COVID-19 expenses, during the four-month period from March to June 2020. Healthcare services expenditures also dropped 38% in […]
Learn More

Physician Fee Schedule Updates May Increase Reimbursement, Time with Patients

Some updates to the evaluation/management codes on the 2021 Physician Fee Schedule will provide greater reimbursement to physicians and allow them to spend more time with patients, CMS and medical societies said. According to CMS, the code sets that it is finalizing will increase the value of certain services. These include: cognitive impairment assessment and care […]
Learn More
Diversifying Revenue Generators and Pursuing Digital Transformation

Diversifying Revenue Generators and Pursuing Digital Transformation

Recently, HealthLeaders hosted its first ‘Virtual Happy Hour CFO Roundtable’ sponsored by Nuance, gathering executives to address the financial and technological challenges facing the health system during the ongoing COVID-19 pandemic. The hour-long roundtable brought together healthcare executives from provider organizations ranging across the East Coast to the Midwest to delve into two key strategic […]
Learn More
Predictive Healthcare Forecasting Key to Provider Survival in 2021

Predictive Healthcare Forecasting Key to Provider Survival in 2021

Healthcare forecasting that can adapt quickly to changes could be as critical to a provider organization’s survival in 2021 as wearing a mask to stop the spread of COVID-19, experts at PwC’s Health Research Institute are saying. Nearly three-quarters of healthcare executives (74 percent) recently surveyed by the Health Research Institute said their organizations would […]
Learn More
How AI is Lending Hand in Healthcare

How AI is Lending Hand in Healthcare

Healthcare seems to be important in all areas where Artificial Intelligence (AI) is promising. This likelihood is because healthcare services are overwhelmed by workforce shortages, inadequate medication, increased patient burdens, and inaccurate diagnosis, all of which may help a degree by modern technologies. Imminent prospects for AI in healthcare comprise health assistance and medication management, […]
Learn More
CMS Updates Part B Payment Information For Covid-19 Treatments

CMS Updates Part B Payment Information For Covid-19 Treatments

A version of this article was first published December 16, 2020, by HCPro’s Revenue Cycle Advisor, a sibling publication to HealthLeaders. CMS released new and updated FAQs on Medicare Part B billing and reimbursement for COVID-19 treatments and vaccines. The information updated December 9 is included in Section BB, Drugs and Vaccines under Part B of CMS’ COVID-19 […]
Learn More
x